Article
Breast cancer resistance protein polymorphism ABCG2 c.421C>A (rs2231142) moderates the effect of valproate on lamotrigine trough concentrations in adults with epilepsy.
Fundamental & clinical pharmacology - 1 Apr 2024
Šušak Sporiš Ivana, Božina Nada, Klarica Domjanović Iva, Sporiš Davor, Bašić Silvio, Bašić Ivana, Lovrić Mila, Ganoci Lana, Trkulja Vladimir
Abstract excerpt
BACKGROUND: Valproate inhibits clearance of lamotrigine and greatly increases its concentrations. We assessed whether this effect was moderated by a polymorphism (ABCG2 c.421C>A) of the breast cancer resistance protein. METHODS: In two consecutive independent studies in adults with epilepsy on lamotrigine monotherapy or cotreated with valproate: (i) Exposure to valproate was considered treatment, (ii)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
